Challenges of Treating Acute Coronary Syndrome

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this video, from AJMCtv, Peter Berger, MD, FACC, FAHA, chairman of cardiology and co-director of the Geisinger Heart & Vascular Institute and director of the Cardiovascular Center for Clinical Research at Geisinger Clinic in Danville, Pennsylvania, discusses the challenge of individualizing antiplatelet treatment for acute coronary syndrome (ACS) patients.

Related Articles
Improved care for HIV-infected patients within the Kaiser Permanente system has essentially reversed their previously reported increased heart attack risk.
If your New Year’s resolutions include being healthier and more positive, a new study suggests that you could be killing 2 birds with 1 stone.
Mylan and Teva have separately announced the US launches of their respective valsartan tablets, the generic version of Novartis’ antihypertensive agent, Diovan.
The number of pharmacies accepting electronic prescriptions for controlled substances has increased substantially in a short time period.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$